William Blair & Company
FMI

William Blair & Company’s Foundation Medicine, Inc. FMI Stock Holding History

William Blair & Company’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-34,426
Closed -$854K – 1700
2017
Q1 		$854K Sell
34,426
-31,640
-48% -$789K 0.01% 751
2016
Q4 		$1.17M Sell
66,066
-1,878
-3% -$40.5K 0.01% 617
2016
Q3 		$1.59M Sell
67,944
-2,096
-3% -$47.6K 0.01% 544
2016
Q2 		$1.31M Sell
70,040
-13,310
-16% -$241K 0.01% 564
2016
Q1 		$1.51M Sell
83,350
-1,874
-2% -$30.2K 0.01% 518
2015
Q4 		$1.79M Buy
85,224
+9,262
+12% +$179K 0.02% 497
2015
Q3 		$1.4M Sell
75,962
-14,450
-16% -$361K 0.01% 643
2015
Q2 		$3.06M Buy
90,412
+19,838
+28% +$798K ﹤0.01% 1204
2015
Q1 		$3.4M Sell
70,574
-16,580
-19% -$752K 0.01% 1154
2014
Q4 		$1.94M Buy
+87,154
New +$2.01M ﹤0.01% 1301

Other funds holding FMI

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
DGI
Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

William Blair & Company's FMI Position: Q2 2017 in Review

William Blair & Company sold out of Foundation Medicine, Inc. (FMI) in Q2 2017, closing a stake of 34,426 shares — an estimated $854K sold.

William Blair & Company first reported a position in FMI in Q4 2014 and held it in 10 quarters. The position peaked at $3.4M in Q1 2015. 103 funds tracked by Wall St. Rank hold FMI as of Q2 2017.

  • William Blair & Company reported no remaining Foundation Medicine, Inc. position as of Q2 2017 after selling out during the quarter.
  • William Blair & Company sold 34,426 Foundation Medicine, Inc. shares in Q2 2017, an estimated $854K.
  • William Blair & Company first reported a position in Foundation Medicine, Inc. in Q4 2014 and held it in 10 quarters.
  • William Blair & Company's Foundation Medicine, Inc. position peaked at $3.4M in Q1 2015.
  • 103 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q2 2017.

Based on William Blair & Company's 13F filing for Q2 2017, filed 4 Aug 2017.